Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Case Definition Workshop

May 20-23, 2001

During May 20-23, 2001, the Centers for Disease Control and Prevention (CDC) sponsored a workshop on Issues Related to the Chronic Fatigue Syndrome (CFS) Research Case Definition. This workshop was designed to follow-up on three areas identified at last May's case definition workshop:

  1. Use of the Case Definition: To identify ambiguities (e.g., in symptoms, and exclusionary conditions) in the 1994 research case definition that must be resolved;
  2. Standardization of Classification Instruments: To identify how investigators currently measure variables in the case definition, and which standard instruments should be used in research related to revising the case definition; and
  3. Study Design and Sample Collection in Defined Populations: To identify target populations and study designs to generate data for revising the case definition.

Our intention for the 2001 workshop was to continue the process begun last year. There was agreement that revisions to the CFS research case definition should be based on empiric data. However, population-based data required for revision are not yet available. As an interim measure, participants were asked to identify ambiguities in the 1994 case definition, to identify instruments that provide the best objective measures of multi-dimensional constructs used in the case definition (such as fatigue, cognition, and pain), and to address study designs that will yield empiric data for revision of the case definition.

The first day's objectives were to discuss ambiguous terms, review conditions that would exclude a subject from a research classification of CFS, and review classification instruments. The presentations and discussion made it clear that the research case definition is not refined enough to allow systematic and reproducible application. At least part of the problem is due to the complexity of the symptom group associated with CFS. Fatigue, cognition, pain, sleep disorders, and psychiatric diagnoses are each difficult to measure objectively, and current instruments may be inadequate for the complex integrated processes affected by CFS. There was agreement that CFS case ascertainment would be improved if the research community could formulate guidelines to assist researchers in uniformly applying the case definition. To this end, two working groups were formed to compile the findings of the participants. One group, led by Dr. Klimas, dealt with exclusionary conditions, and the other, led by Dr. Jason, dealt with instruments.

The second day's objective was to consider information to guide the group toward study designs that will yield population-based empiric data required for an improved CFS case definition. Presenters were first asked to review how research in other ill-defined conditions (lupus, depression, and sleep disorders) progressed to identify objective markers of disease. We then discussed model systems (postinfective fatigue from Epstein-Barr virus infection, Q fever, and immune modulation from latent herpesvirus proteins) and information (neuroendocrine and chronobiology) that could guide research about the pathophysiology of CFS. Finally, we closed the day with presentations on integrating multi-source data required for an empiric case definition.

On the third day, we discussed reports by the two working groups. We agreed to prepare a review article critiquing the 1994 CFS Research Case Definition and submit it for publication by July 2001. We also agreed that CDC would take the lead in facilitating communication and forming an International Collaborative Group to test standard instruments and collect data that could be used to propose an empiric-data-based revision to the case definition by 2003.

Meeting Participants

Invited participants included:

  • Birgitta Evengard
    Huddinge University Hospital, Stockholm, Sweden
  • Nelson Gantz
    Polyclinic Hospital, Harrisburg, PA
  • Ron Glaser
    Ohio State University, Columbus, OH
  • Christine Heim
    Emory University, Atlanta, GA
  • Leonard Jason
    DePaul University, Chicago, IL
  • James Jones
    National Jewish Medical Center, Denver, CO
  • K. Kimberly Kenney
    CFIDS Association of America, Charlotte, NC
  • Nancy Klimas
    University of Miami/VA Medical Center, Miami, FL
  • Gundrun Lange
    New Jersey Medical School, East Orange, NJ
  • Andrew Lloyd
    University of South Wales, Australia
  • Andrew Miller
    Emory University, Atlanta, GA
  • Harvey Moldofsky
    University of Toronto, Toronto, Canada
  • Benjamin Natelson
    New Jersey Medical School, East Orange, NJ
  • Thomas J. O'Laughlin
    Physical Medicine, Rehabilitation & Electromyography, Fresno, CA
  • Dimitris Papanicolaou
    Emory University, Atlanta, GA
  • Eng Tan
    Scripps Institute, La Jolla, CA
  • Peter White
    St. Bartholomew's Hospital, London, UK

CDC participants were:

  • Catherine Campbell
  • Kevin Karem
  • Rosane Nisenbaum
  • Mangalathu Rajeevan
  • Daya Ranamukhaarchchi
  • William Reeves
  • John Stewart
  • Elizabeth Unger
  • Suzanne Vernon

Meeting Agenda

Monday, May 21, 2001

  • Overview and Review (Dr. William Reeves)
  • Operationalization & Ambiguities (Dr. Nancy Klimas)
  • Exclusionary Criteria (Dr. John Stewart)
  • International Connotation and Measurement of Fatigue (Dr. B Evengard)
  • Instruments and Measurement of Fatigue (Dr. Leonard Jason)
  • Instruments and Measurement of Cognition (Dr. Gudrun Lange)
  • Instruments and Measurement of Pain (Dr. Thomas O'Laughlin)
  • Evaluation and Measurement of Function & Well-being (Dr. Jim Jones)
  • Evaluation and Measurement of Remission & Recovery (Dr. Nelson Gantz)

Tuesday, May 22, 2001

  • Lupus (Dr. Eng Tan)
  • Depression (Dr. Christine Heim)
  • Sleep Disorders (Dr. Harvey Moldofsky)
  • Infectious Models of Chronic Fatigue - Focus on Mononucleosis (Dr. Peter White)
  • Infectious Models of Chronic Fatigue - Focus on Q fever (Dr. Andrew Lloyd)
  • Neuroendocrine Models of Chronic Fatigue (Dr. Dimitris Papanicolaou)
  • Immune Modulation by Latent Herpesvirus Proteins (Dr. Ron Glaser)
  • Data Integration (Dr. Kathleen McCormick)
  • Chronobiology of CFS (Dr. Benjamin Natelson)
  • Study Design and the Sample (Dr. Suzanne Vernon)
  • Challenges for Statistical Analysis (Dr. Rosane Nisenbaum)

Wednesday, May 23, 2001

  • Working Group on Instruments (Dr. Leonard Jason)
  • Working Group on Exclusionary Conditions (Dr. Nancy Klimas)
 

CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO